Literature DB >> 1117129

Characterization of chemotactic activity produced in vivo by a cell-mediated immune reaction in the guinea pig.

A E POSTLETHWAITE, R Snyderman.   

Abstract

A system that allows repeated sampling of peritoneal fluid at various time intervals has been adapted to study mechanisms of leukocyte accumulation in vivo. Application of this technique in guinea pigs exhibiting delayed hypersensitivity (DH) to horse radish peroxidase (HRPO) has allowed characterization of some events after i.p.challenge with the sensitizing antigen. Within 24 hr of the administration of HRPO i.p. to such animals there is a significant increase in the number of peritoneal macrophages and in the chemotactic activity (CTX) for macrophages in the sampled peritoneal fluid. At 48 and 72 hr the CTX returns to the pre-challenge level and i.p. macrophages appear to be actively phagocytic. Molecular sieve chromatograms of concentrated peritoneal fluid obtained 24 hr after i.p. challenge with HRPO and of supernatants derived from immune spleen cells cultured in the presence of HRPO in the presence of HRPO in vitro revealed that the major portion of CTX for homologous macrophages eluted in the region of the 12,500 dalton protein marker. The partially purified CTX obtained from peritoneal fluid and supernatants of spleen cell cultures was heat stable (56 degrees C for 30 min) and was destroyed by trypsin digestion. These data demonstrate that a chemotactic factor (LDCF) obtained in vitro, is present in vivo at the site of a cell-mediated immune reaction. Moreover, these observations demonstrate the feasibility of studying the kinetics of leukocyte accumulation and the production of mediators of inflammation at the site of well defined immunologic reactions in vivo.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1117129

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Characterization of three macrophage chemotactic factors from PPD-induced delayed hypersensitivity reaction sites in guinea pigs, with special reference to a chemotactic lymphokine.

Authors:  M Honda; H Hayashi
Journal:  Am J Pathol       Date:  1982-08       Impact factor: 4.307

2.  Selective chemotaxis of Ia antigen-positive blood monocytes in response to a macrophage chemotactic lymphokine extractable from PPD-induced delayed hypersensitivity reaction site in guinea-pigs.

Authors:  T Yoshimura; M Honda; H Hayashi
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

3.  Lymphocyte chemotaxis in inflammation. IX. Further characterization of lymphocyte chemotactic lymphokines produced by purified protein derivative-stimulation in vitro and in vivo.

Authors:  S Harita; Y Shimokawa; Y Mibu; M Ishida; H Hayashi
Journal:  Immunology       Date:  1984-02       Impact factor: 7.397

4.  Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factor.

Authors:  T W Jungi; D D McGregor
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 5.  Relationship of tumor leucocytic infiltration to host defense mechanisms and prognosis.

Authors:  J W Kreider; G L Bartlett; B L Butkiewicz
Journal:  Cancer Metastasis Rev       Date:  1984       Impact factor: 9.264

6.  The chemical mediation of delayed hypersensitivity skin reactions. I. Purification of a macrophage-chemotactic factor from bovien gamma-globulin-induced skin reactions in guinea pigs.

Authors:  T Kambara; K Ueda; S Maeda
Journal:  Am J Pathol       Date:  1977-05       Impact factor: 4.307

7.  Human monocyte-derived chemotactic factor for granulocytes.

Authors:  T Tono-Oka; M Nakayama; S Matsumoto
Journal:  Immunology       Date:  1980-04       Impact factor: 7.397

8.  Collagen-and collagen peptide-induced chemotaxis of human blood monocytes.

Authors:  A E Postlethwaite; A H Kang
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

9.  Formation of multinucleated giant cells from human monocyte precursors. Mediation by a soluble protein from antigen-and mitogen-stimulated lymphocytes.

Authors:  A E Postlethwaite; B K Jackson; E H Beachey; A H Kang
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.